Inspiration Hlt Regulatory News (IHC)

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

New Generation Wireless Brain Monitoring CFM unit granted CE mark 

and renewal of Neotech distribution agreement.

Inspiration Healthcare Group plc (AIM: IHC), the global medical device company, is delighted to announce that its new generation CFM (Cerebral Function Monitor)

unit, the Unique+, designed for use in neonatal applications has been granted a CE mark*. The product will be released for sale in the UK starting in February 2018, followed swiftly by major European markets and other key territories in the world as the product becomes registered with the respective regulatory bodies.

The Cerebral Function Monitoring is designed to monitor the electrical activity in the brain of neonatal infants and has been a key component of Inspiration Healthcare's product offering since 2004. The new Unique+ is the next generation of CFM offered by Inspiration with the further refinement of both hardware and software elements, and the addition of smart features to improve connectivity and the user experience, including:

· A combined amplifier and headbox in one battery powered, lightweight unit and modern user interface

· Simple identification of electrode placement with LED-lit connection points for single channel and dual channel monitoring, and

· Connectivity via USB, Bluetooth and now the additional option of WiFi enabling remote connectivity to PCs or hospital computer networks

The Unique+ is state-of-the-art and can be introduced into previously untapped markets including North America and Russia.

At the same time, the Company is pleased to announce that it has renewed a distribution contract with Neotech Products LLC, the US specialist manufacture of products used in neonatal intensive care applications and has agreed a further two year term. In the current year, the Company estimates the total revenues from the sale of Neotech products in the UK will amount to in excess of £0.1m.

Commenting today, Neil Campbell Inspiration Healthcare's Chief Executive Officer said: "The Unique+ CFM re-affirms Inspiration Healthcare's commitment to improving diagnostic and treatment of the newborn brain. It also shows our commitment to investing in new technology and developing our product portfolio that will allow us to penetrate further into key international markets. We are also delighted to extend our relationship with Neotech and continuing as the UK distributors for their medical devices."

* CE marking is a mandatory conformity marking for certain products sold within the European Economic Area (EEA).

Enquiries:

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) is a global supplier of medical technology for critical care, operating theatre and other medical applications. The Company provides high quality innovative products to patients and caregivers around the world that help to improve patient outcomes and efficiencies of healthcare organisations with patient focused customer service and technical support.

The Company's own brand of critical care solutions span non-invasive respiratory management, thermoregulation and diagnostics, and patient warming for newborns through to adults in intensive care and the operating theatre, whilst the distribution business supplies solutions to support specialised surgical procedures and infusion therapies.

Present in over 50 countries worldwide, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving the quality of life of patients, working in close collaboration with key opinion leaders and stakeholders in the clinical and medical community across the globe.

Further information on Inspiration Healthcare can be seen at www.inspiration-healthcare.com